,,iii  #aafth ,,congress  #ast ,session 
,s4 ,,res4 #aeg  ,,in ,,the ,,senate    
,,of ,,the ,,united ,,states  ,april    
#aj1 #bjai,mr4 ,isakson 7for himself and
 ,ms4 ,stabenow7 submitted the following
 resolution2 which was considered and   
agreed to  ,,resolution  ,supporting the
 designation of ,april #bjai as         
,parkinson's ,awareness ,month4         
,whereas ,parkinson's disease is a      
chronic1 progressive neurological       
disease and the second most common      
neurodegenerative disease in the ,united
 ,states2 ,whereas1 although there is   
inadequate data on the incidence and    
prevalence of ,parkinson's disease1 the 
disease is estimated to affect between  
#ejj1jjj and #a1jjj1jjj individuals in  
the ,united ,states1 with that number   
expected to more than double by #bjdj2  
,whereas1 according to the ,centers for 
,disease ,control and ,prevention1      
,parkinson's disease is the #adth       
leading cause of death in the ,united   
,states2 ,whereas millions of           

individuals in the ,united ,states are  
greatly impacted by ,parkinson's        
disease1 including the caregivers1      
family members1 and friends of          
individuals living with ,parkinson's    
disease2 ,whereas research suggests that
 the cause of ,parkinson's disease is a 
combination of genetic and environmental
 factors1 but the exact cause of the    
disease in most individuals is still    
unknown2 ,whereas1 as of ,march #bjai1  
there is no objective test or biomarker 
with which to diagnose ,parkinson's     
disease2 ,whereas there is no known cure
 or drug to slow or halt the progression
 of ,parkinson's disease1 and available 
treatments are limited in their ability 
to address the medical needs of patients
 and remain effective over time2        
,whereas the symptoms of ,parkinson's   
disease vary from person to person and  
may include-- 7#a7 tremors2  7#b7       
slowness of movement and rigidity2  7#c7
 problems with gait and balance2  7#d7  
disturbances in speech and swallowing2  

7#e7 cognitive impairment and dementia2 
7#f7 mood disorders2 and  7#g7 a variety
 of other nonmotor symptoms2  ,whereas  
volunteers1 researchers1 caregivers1 and
 medical professionals are working to   
improve the quality of life of--  7#a7  
individuals living with ,parkinson's    
disease2 and  7#b7 the families of those
 individuals2 and  ,whereas increased   
research1 education1 and community      
support services are needed-- 7#a7 to   
find more effective treatments2 and     
7#b7 to provide access to quality care  
to individuals living with ,parkinson's 
disease3 ,now1 therefore1 be it  ,that  
the ,senate-- 7#a7 designates ,april    
#bjai as ,parkinson's ,awareness ,month2
  7#b7 supports the goals and ideals of 
,parkinson's ,awareness ,month2  7#c7   
continues to support research to find   
better treatments and a cure for        
,parkinson's disease2  7#d7 recognizes  
the individuals living with ,parkinson's
 disease who participate in vital       
clinical trials to advance the knowledge

 of the disease2 and  7#e7 commends the 
dedication of the organizations1        
volunteers1 researchers1 and millions of
 individuals across the ,united ,states 
who are working to improve the quality  
of life of--  7,a7 individuals living   
with ,parkinson's disease2 and  7,b7 the
 families of those individuals4